We are excited to announce that the full replay of our recent webinar, co-hosted with NanoVation Therapeutics on Sept. 24, is now available! This landmark event attracted over 600 registrants and featured groundbreaking insights into next-generation Lipid Nanoparticle (LNP) technologies and their applications in extra-hepatic nucleic acid delivery.
???? Watch the full webinar replay here
Key Highlights from the Webinar:
- Pieter Cullis, co-Founder & Board Chair of NanoVation Therapeutics, provided a fascinating historical overview of LNPs, showing how these particles have evolved into life-saving tools in modern medicine, including their role in COVID-19 vaccines.
- Dominik Witzigmann, co-Founder & CEO of NanoVation Therapeutics, discussed the future of RNA therapeutics and the challenges of tissue-specific delivery, emphasizing that there is no “one-size-fits-all” solution for RNA delivery across different tissues.
- Laura Evgin, Assistant Professor at The University of British Columbia, introduced innovative CAR-T cell therapies, with a focus on in vivo CAR-T generation using nanomedicine for greater precision in treating diseases like cancer.
Exceptional Feedback from Participants
The feedback we received from the webinar has been overwhelmingly positive. Participants gave the webinar an overall satisfaction rating of 9.2/10, with particularly high scores for the scientific content (9.4/10) and organization (9.1/10). Many attendees noted that the presentations were clear, informative, and highly relevant to their work, while the interactive polls and lively Q&A session added great value. Nearly 60% of participants stayed for over 90 minutes, showing a deep level of engagement.
Here’s what some participants had to say:
“Extremely well-organized, wonderful speakers, relaxed atmosphere, terrific content.”
“Great to hear from thought-leaders on nucleic acid delivery. Would love more time for Q&A.”
“Loved the interactive polls, but would suggest giving more time to respond to them.”
Why Watch the Replay?
This webinar offered cutting-edge insights from leading experts in the field, covering both the past and future of LNPs and their transformative potential in medicine. Whether you are involved in research, industry, or simply interested in nanomedicine, this session is not to be missed!
- Interactive Features: Switch between gallery and speaker views for a more dynamic experience, especially during the lively Q&A session.
- Searchable Transcription: Find key moments quickly using Zoom’s transcription tool, allowing you to search for specific topics or keywords.
- Q&A Session: Over 30 audience questions were answered during the webinar, with discussions ranging from improving RNA delivery to future breakthroughs beyond mRNA vaccines.
About NanoVation Therapeutics.
NanoVation Therapeutics (Ntx) is a cutting-edge biotechnology company focused on the development of next-generation lipid nanoparticle (LNP) technologies for the targeted delivery of nucleic acids, including RNA therapeutics. As a recent Platinum member of the European Technology Platform for Nanomedicine (ETPN), Ntx brings its expertise and innovative solutions to the forefront of the European nanomedicine community, fostering collaboration to advance groundbreaking therapies with real-world impact. Their recent partnership with Novo Nordisk highlights their growing influence in the biotech landscape. Learn more: https://nanovationtx.com
What’s Next?
This webinar is just the beginning of an exciting collaboration between ETPN and NanoVation Therapeutics, as we continue to push the boundaries of nanomedicine and explore new frontiers in RNA and LNP technologies. Stay tuned for more updates and future events!
If you’re interested in becoming a member of ETPN and joining our growing community, click here to learn more.